Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Inflammatory Bowel Diseases|April 13, 2025
A Multicenter Study to Assess Avoidant/Restrictive Food Intake Disorder in Patients with Inflammatory Bowel DiseaseLaurie B Grossberg, Kajali Mishra, Loren G Rabinowitz, et al.
Digestive Diseases and Sciences|January 27, 2025
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International StudySailish Honap, Bénédicte Caron, Jacob E Ollech, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel DiseasesKonstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Digestive Diseases and Sciences|July 4, 2024
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel DiseaseAlexander Abadir, Angela Troia, Hyder Said, et al.
Annals of Gastroenterology|May 21, 2026
Postpartum nonsteroidal anti-inflammatory drug exposure does not increase risk for flare in patients with inflammatory bowel diseaseLoren G Rabinowitz, Tina Deyhim, Joyce Lee, et al.
European Journal of Gastroenterology & Hepatology|February 20, 2016
European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysisUri Kopylov, Konstantinos H Katsanos, Christien Janneke van der Woude, et al.
The Lancet. Gastroenterology & Hepatology|January 13, 2022
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectivesKonstantinos Papamichael, Waqqas Afif, David Drobne, et al.
Inflammatory Bowel Diseases|June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective StudyUri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.
BMC Genomics|June 20, 2014
Relationship between genome and epigenome--challenges and requirements for future researchGeneviève Almouzni, Lucia Altucci, Bruno Amati, et al.
Pageof 15